Align Technology (ALGN)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Align Technology | ALGN | Healthcare | Medical Devices | 98 | 12.8% |
| Current Price (11/20) | $268.77 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 2,331.2 | |||
| Sales Growth Forecast | 19.2% | |||
| Net Profit Margin | 19.8% | |||
| Projected Shares Outstanding | 81.43 | |||
| EPS - Five year Forecast | $13.62 | |||
| Average P/E Ratio | 36.0 | |||
| Projected Average Price | $490.27 | |||
| Price Appreciation (Annualized) | 12.8% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 12.8% | |||
| Quality | ||||
| Financial Strength | 84 | 21.0 | ||
| EPS Stability | 97 | 24.1 | ||
| Industry Sales Growth Rate | 12.0% | 20.0 | ||
| Industry Net Profit Margin | 13.5% | 18.3 | ||
| Calculated Quality Rating | 83.4 | |||
| Fool CAPS | ||||
Total Players
467
Outperforms
52
Underperforms
All-Stars (179)
167
Outperforms (93%)
12
Underperforms
|
||||
| Fundamental Data Updated: 09/13/2019 | ||||